AN2 THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.32 USD | +1.75% |
|
-6.07% | -88.68% |
| Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
| Apr. 02 | JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform | MT |
Chart calendar AN2 Therapeutics, Inc.
9480ac6598ce9e9e75af20d894d55.nIoEC69x7JZKqsJtumFxau4VgdhXCrwnqC8olDXetyc.zeFuep8EmKAF7bM0zgpAX6hSxJ0bTPV9w2Af0mSHw0_I60VNziGarjifkw~53636c99ff62468cb16adb69675279dc
Upcoming events on AN2 Therapeutics, Inc.
Past events on AN2 Therapeutics, Inc.
| 2024-03-28 04:10 pm | Q4 2023 Earnings Release |
| 2024-02-14 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-29 08:45 am | Evercore ISI HealthCONx Conference |
| 2023-11-15 03:00 pm | Stifel Healthcare Conference |
| 2023-11-09 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-14 12:15 pm | IDWeek Conference - Poster No :2135 |
| 2023-10-14 12:15 pm | IDWeek Conference - Poster No :2556 |
| 2023-10-14 12:15 pm | IDWeek Conference - Poster No :2144 |
| 2023-10-14 10:54 am | IDWeek Conference - Poster No :2064 |
| 2023-10-12 08:48 am | IDWeek Conference - Poster No :32 |
| 2023-08-10 04:10 pm | Q2 2023 Earnings Release |
| 2023-06-08 04:30 pm | Jefferies Global Healthcare Conference |
| 2023-06-07 11:00 am | Annual General Meeting |
| 2023-05-16 02:00 pm | JMP Securities Life Sciences Conference |
| 2023-05-11 04:10 pm | Q1 2023 Earnings Release |
| 2023-03-29 04:01 pm | Q4 2022 Earnings Release |
| 2023-03-14 11:20 am | Oppenheimer Healthcare Conference |
| 2023-03-07 09:10 am | Cowen Health Care Conference |
| 2023-02-14 05:00 pm | SVB Securities Global Biopharma Conference |
| 2022-11-30 02:15 pm | Evercore ISI HealthCONx Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -42,3 -41,6 -1.59% | -69,6 -70,9 1.74% | -79,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -64,7 -66,9 3.27% | 0,00 |
|
Net income Million USD | Released Forecast Spread | -28,1 | -42,8 -43,1 0.67% | -64,7 -67,3 3.79% | -81,1 |
|
EPS USD | Released Forecast Spread | -25,0 | -2,79 -2,62 -6.35% | -2,74 -2,94 6.8% | -2,57 |
| Announcement Date | 04/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,68 -9,90 22.39% | -10,3 -11,5 9.76% | -11,8 -11,5 -2.79% | -12,5 -11,9 -5.28% | -16,0 -13,6 -17.93% | -16,6 -16,8 0.89% | -18,2 -16,2 -12.22% | -18,8 -20,1 6.22% | -19,4 | -19,6 | -19,8 | -20,3 | -20,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -19,1 11.48% | ||||||||||||
|
Net income Million USD | Released Forecast Spread | -9,48 -8,97 -5.67% | -10,1 -10,9 6.87% | -11,3 -11,9 4.45% | -11,8 -12,6 6.02% | -15,3 -13,3 -15.5% | -15,8 -16,7 5.18% | -16,7 -16,2 -3.13% | -16,9 -19,4 13% | -18,9 | -19,8 | -20,7 | -21,8 | -20,0 |
|
EPS USD | Released Forecast Spread | -2,98 -0,92 -224.8% | -0,53 -1,89 71.91% | -0,59 -0,59 0.56% | -0,61 -0,65 5.67% | -0,79 -0,68 -16.18% | -0,81 -0,85 5.08% | -0,65 -0,63 -3.72% | -0,57 -0,75 23.49% | -0,62 | -0,63 | -0,65 | -0,67 | -0,67 |
| Announcement Date | 10/05/22 | 11/08/22 | 09/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for AN2 Therapeutics, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANTX Stock
- Calendar AN2 Therapeutics, Inc.
